Takeda is teaming up with the Dutch testing firm Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status. Enzyre will receive ...

A Philadelphia company's breakthrough treatment for hemophilia has passed a big test. Hemophilia is a condition where the blood doesn't clot like it's supposed to, so people can have severe bleeding ...

The best treatment for any disease, says Sigilon Therapeutics CEO Rogerio Vivaldi, M.D., is the body’s own cells. “If we allow cells to do what they are designed to do, that is the best treatment,” ...

If a patient tests positive for antibodies to AAVRh74var, Beqvez should not be administered. Beqvez is indicated for the treatment of adults with moderate to severe hemophilia B who currently use ...

Study demonstrates superiority, showing both statistically significant and clinically meaningful reduction in annualized bleeding rate with a generally well-tolerated safety profile compared to ...

The primary symptoms of hemophilia A are excessive bleeding and easy bruising. Excessive bleeding may occur after major trauma in people with hemophilia A, but it can also occur after more minor ...

Hundreds of years after hemophilia was first discovered, a new medication that was successfully tested on a Fort Collins man could be an answer for those living with Hemophilia A. Andrew Schulz, a ...

MedPage Today has been reporting on a variety of subjects relating to hemophilia A, from prevalence to treatment. Answer these questions to see how much you’ve retained. After taking the quiz, scroll ...

HYMPAVZI offers a combination of superior bleed protection compared to on-demand (OD) treatment that is well-tolerated with a straightforward, once-weekly subcutaneous injection administration that ...

Roche's new hemophilia drug Hemlibra dramatically reduced bleeding in a broad population of hemophilia patients, results from two clinical trials showed. The results set Hemlibra up to take a dominant ...

LONDON, May 21 (Reuters) - Roche's new hemophilia drug Hemlibra dramatically reduced bleeding in a broad population of hemophilia patients, results from two clinical trials showed on Monday, setting ...